Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
12/2014
12/10/2014CN102203079B 作为激酶抑制剂的吡啶甲酰胺衍生物 As pyridinecarboxamide derivative kinase inhibitors
12/10/2014CN102137925B 同时诱导CTL和γδT细胞的方法 Simultaneous induction of CTL and γδT cells
12/10/2014CN102083427B 碳酸酐酶ix的抑制剂 Carbonic anhydrase inhibitors ix
12/10/2014CN102038634B 一种含有助溶剂的紫杉烷类药物溶液及其制备方法 A co-solvent alkyl taxane class of drugs containing solution and its preparation method
12/10/2014CN101993478B Eb病毒潜伏膜蛋白2多表位重组蛋白及应用 Eb virus latent membrane protein 2 multi-epitope recombinant proteins and application
12/10/2014CN101952433B 在疾病的诊断与治疗中的PTHrP，其亚型及其拮抗剂 PTHrP in the diagnosis and treatment of disease, and its subtypes and antagonists
12/10/2014CN101861164B 朊病毒蛋白相关疾病的治疗 Treatment of a disease associated prion protein
12/10/2014CN101842490B 抗原组合物及其在核酸的靶向递送中的应用 Antigen composition and its application in the targeted delivery of nucleic acids
12/10/2014CN101827936B Cdh3肽以及含有cdh3肽的药剂 Cdh3 peptides and peptide drug containing cdh3
12/10/2014CN101721702B 用于治疗TNF-α相关疾病的人抗体的制剂 For the treatment of TNF-α-related diseases of a human antibody preparation
12/10/2014CN101700382B 癌痛消滴丸 Pain elimination Dripping Pills
12/10/2014CN101679239B 组蛋白脱乙酰酶抑制剂 Histone deacetylase inhibitors
12/10/2014CN101678078B Sparc及其使用方法 Sparc and methods of use
12/10/2014CN101065151B 半胱氨酸改造的抗体和偶联物 Cysteine ​​engineered antibody and conjugate
12/09/2014US8909325 Radioactive emission detector equipped with a position tracking system and utilization thereof with medical systems and in medical procedures
12/09/2014US8906960 Synergistic effect of tocotrienols and curcumin
12/09/2014US8906947 Method for the separation and purification of epothilones
12/09/2014US8906943 Synthetic compounds and methods to decrease nicotine self-administration
12/09/2014US8906852 Inhibitors of protein tyrosine kinase activity
12/09/2014US8906422 Method for inhibiting cancer using arsenic trioxide
12/09/2014US8906409 Acoustically sensitive drug delivery particles comprising non-lamellar forming phosphatidylcholine
12/09/2014US8906376 Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease
12/04/2014US20140357586 Solid Carriers for Improved Delivery of Active Ingredients in Pharmaceutical Compositions
12/02/2014US8901280 Antibody against RGD in amino acid sequence of extracellular matrix protein and production method and use of the same
12/02/2014US8901140 6-amino quinazoline or 3-cyano quinoline derivatives, preparation methods and pharmaceutical uses thereof
12/02/2014US8901138 Sulfoximine substituted quinazolines for pharmaceutical compositions
12/02/2014US8901111 Aryl-substituted heterocyclic urea modulators of fatty acid amide hydrolase
12/02/2014US8901083 Administration of angiocidin for the treatment of leukemia
12/02/2014US8901082 Immunity-inducing agent and method for detection of cancer
12/02/2014US8900584 Human CDR-grafted antibody and antibody fragment thereof
11/2014
11/27/2014US20140351960 Artery- and vein-specific proteins and uses therefor
11/27/2014US20140350009 Pyrazolylbenzothiazole derivatives and their use as therapeutic agents
11/27/2014US20140349292 Oligonucleotide n3'-->p5' thiophosphoramidates: their synthesis and use
11/27/2014US20140348849 Compounds and Method for Modulating Inflammatory Reactions
11/27/2014US20140348784 Compositions and methods for treatment of angiogenesis in pathological lesions
11/27/2014US20140348783 Vaccine immunotherapy for immune suppressed patients
11/27/2014US20140348782 Vaccine immunotherapy for immune suppressed patients
11/25/2014US8895722 Splice-region antisense composition and method
11/25/2014US8895721 RNA interference mediating small RNA molecules
11/25/2014US8895718 RNA interference mediating small RNA molecules
11/25/2014US8895714 Biological products
11/25/2014US8895605 Pyrrolidine-substituted flavones as radio-sensitizers for use in the treatment of cancer
11/25/2014US8895554 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes, and Parkinson's disease
11/25/2014US8895543 Vinca derivatives
11/25/2014US8895306 Oxadiazoline ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
11/25/2014US8895245 Inhibitors of human EZH2 and methods of use thereof
11/25/2014US8895087 Composition to enhance the bioavailability of curcumin
11/25/2014US8894969 Method and device for radiotherapy
11/20/2014US20140342930 Methods for selective targeting
11/20/2014US20140342405 Vascular endothelial growth factor 2
11/20/2014US20140341982 Vaccination With Immuno-Isolated Cells Producing An Immunomodulator
11/20/2014US20140341948 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
11/20/2014US20140341886 TREATMENT WITH ANTI ErbB2 ANTIBODIES
11/18/2014US8889715 Substituted pyridoxine-lactam carboxylate salts
11/18/2014US8889697 Metabolites of the janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile
11/18/2014US8889684 Azaindolylphenyl sulfonamides as serine/threonine kinase inhibitors
11/18/2014US8889672 Compounds, formulations, and methods of protein kinase C inhibition
11/18/2014US8889664 Phosphatidylinositol 3-kinase inhibitors and methods of their use
11/18/2014US8889658 Phosphonate compounds
11/18/2014US8889616 MUC1 based glycolipopeptide vaccine with adjuvant
11/18/2014US8889419 Methods for enhanced virus-mediated DNA transfer using molecules with virus- and cell-binding domains
11/18/2014US8889135 Methods of administering anti-TNFα antibodies
11/13/2014US20140336210 Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancers
11/13/2014US20140336143 Treatment of ebv and khsv infection and associated abnormal cellular proliferation
11/13/2014US20140335549 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assays
11/13/2014US20140335086 Modified heat shock protein-antigenic peptide complex
11/13/2014US20140335053 Novel mhc class ii restricted t cell epitopes from the cancer antigen, ny eso-1
11/11/2014US8883856 Compositions and methods for the treatment of inflammatory diseases using topoisomerase inhibitors
11/11/2014US8883827 Azole derivatives as WTN pathway inhibitors
11/11/2014US8883759 Anti-tumor effect potentiator
11/11/2014US8883749 Transcription factor inhibitors and related compositions, formulations and methods
11/11/2014US8883735 Low density lipoprotein-related protein 6 (LRP6)-half life extender constructs
11/11/2014US8883720 Template-fixed beta-hairpin peptidomimetics with CXCR4 antagonizing activity
11/11/2014US8883199 Administration regime for N-hydroxy-4-{2-[3-(N,N-dimethylaminomethyl)benzofuran-2- ylcarbonylamino]ethoxy}benzamide
11/11/2014US8883162 Multivalent antibody complexes targeting IGF-1R show potent toxicity against solid tumors
11/11/2014US8883159 Antibodies against CDCP1 for the treatment of cancer
11/11/2014US8883149 Antibody combinations and use of same for treating cancer
11/11/2014US8882075 Furnace mount
11/06/2014US20140328857 Novel B7-H3L Cell Surface Antigen and Antibodies That Bind Thereto
11/06/2014US20140328844 Methods of use for taci-immunoglobulin fusion proteins
11/04/2014US8877933 Thermodynamically stable form of a tosylate salt
11/04/2014US8877928 Pegylated cyclopamine analogue, preparation method and uses thereof
11/04/2014US8877785 Methods and compositions for enhancing sensitivity of cytotoxic drugs with timely combinatorial therapy with carboxyamidotriazole orotate
11/04/2014US8877771 Treatment of solid tumors with rapamycin derivatives
11/04/2014US8877756 Substituted pteridines
11/04/2014US8877726 Method and medicament for inhibiting the expression of a given gene
11/04/2014US8877718 Antiinfective and antitumoral compounds isolated from tropical lianas
11/04/2014US8877715 Cytotoxic conjugates having neuropeptide Y receptor binding compound
11/04/2014US8877706 Maytansinoid derivatives
11/04/2014US8877182 Expansion of NK cells
10/2014
10/30/2014US20140325691 Regulation of endogenous gene expression in cells using zinc finger proteins
10/30/2014US20140323693 Antibodies To Non-Functional P2X7 Receptor
10/30/2014US20140323494 N-oxides of n-phenyl-2-pyrimidine-amine derivatives
10/30/2014US20140322232 Methods of administering anti-tnfalpha antibodies
10/30/2014US20140322221 Multivalent antibodies and uses therefor
10/30/2014US20140322202 TREATMENT WITH ANTI ErbB2 ANTIBODIES
10/30/2014US20140322134 Treatment and Imaging Methods Using Antibodies to Aminophospholipids
10/28/2014US8871818 Gastrointestinal absorption enhancer mediated by proton-coupled transporter and its preparing method
10/28/2014US8871725 Pharmaceutical combination for the treatment and/or chemosensibilization of refractory tumors to anticancer drugs
10/28/2014US8871721 Methods for inhibiting peritoneal dissemination of cancer cells
1 ... 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 ... 2211